Gérard Soula
Founder bij ADOCIA
Vermogen: 10 M $ op 31-03-2024
Profiel
Gérard Soula is the founder.
He founded Flamel Technologies SA in 1990, where he held the title of Chairman & Chief Executive Officer from 1990 to 2005.
He also founded Adocia SA in 2005 and currently serves as Chairman.
Dr. Soula's current job is as a Director at Glowbl SAS.
His former positions include being a Director at Veloxis Pharmaceuticals A and Life Cycle Pharma A.
Dr. Soula obtained a doctorate degree from Université d'Aix-Marseille.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ADOCIA SA
7.14% | 31-12-2022 | 1 006 455 ( 7.14% ) | 10 M $ | 31-03-2024 |
Actieve functies van Gérard Soula
Bedrijven | Functie | Begin |
---|---|---|
ADOCIA | Founder | 16-12-2005 |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Director/Board Member | - |
Eerdere bekende functies van Gérard Soula
Bedrijven | Functie | Einde |
---|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Founder | 01-01-2005 |
Life Cycle Pharma A/S | Director/Board Member | - |
VELOXIS PHARMACEUTICALS A/S | Director/Board Member | - |
Opleiding van Gérard Soula
Université d'Aix-Marseille | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ADOCIA | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Life Cycle Pharma A/S | |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Technology Services |